10 studies on Matrixyl curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Bottom line: TitrateLab currently tracks 6 published third-party lab tests of Matrixyl across 5 identified manufacturers. Among reports with a positive numeric purity result, the average is 99.58%. Within this published corpus, 0 positive purity results were below 90%, and 0 reports showed measured quantity more than 10% below the label claim. These are batch-level observations, not guarantees of product identity, safety, or vendor quality.
Independent certificate-of-analysis evidence from third-party labs — the data behind the studies. Updated as new COAs are verified. Read the full grey-market analysis →
Within that total, 1 batch has unresolved manufacturer identity. It remains in corpus-level lab evidence and is excluded from named-manufacturer rankings.
Recent certificates: #68561 (99.67%) · #68253 (99.41%) · #97576 (99.795%) · #39134 (99.67%) · #39892 (99.07%) · #86834 (99.874%)
This research provides crucial insights for the rational design of peptide-based cosmetic ingredients, particularly those targeting **collagen stimulation**. Understanding how subtle changes in peptide sequence (e.g.,…
This study highlights the potential of carnosine-derived lipidated peptides as a new class of biomaterials with inherent therapeutic properties. The ability to form tunable hydrogels means CLP could serve as a self-de…
The study yielded compelling results, demonstrating that AAH exhibited significantly lower toxicity in HaCaT cells compared to the positive control, matrixyl, with cell viability remaining robust at 81.52% for AAH-tre…
This research highlights Thêta-Cream as a potentially superior prophylactic agent for managing radiation dermatitis in breast cancer patients, offering a significant improvement over existing standard care. Its abilit…
This study highlights the exciting potential of repurposing peptides with established functions, like collagenesis induction, into novel antimicrobial agents. The demonstrated efficacy against multidrug-resistant Gram…
This research highlights the powerful potential of combining i-PRF with bioactive peptides for regenerative applications in dermatology. The observed synergy suggests a novel approach to enhance skin rejuvenation, imp…
Free, no account — handy when you're working with Matrixyl.
Pro members save studies and unlock the full evidence breakdown and vendor lab data.
Buyer protection: Wrong or defective product? Report it within 7 days. We broker a refund or reship with the vendor.
$12 monthly or $33 lifetime
Create free account